Evidence map›Paper›PMID 42495148›Full record

ArticleFrontiers in microbiology2026

Acute gastrointestinal graft-versus-host disease is associated with reductions of secondary bile acids following allogeneic hematopoietic cell transplantation.

Robin Cagle, Sean Proll, Samuel S Minot, Hayley Purcell, Wentao Zhu, Danijel Djukovic, Congzhou Liu, Tina Fiedler, Martha DeMeules, Marco Mielcarek and 5 more

Abstract read
In one paragraph

Article in Frontiers in microbiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

Robin CagleVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Sean ProllVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Samuel S MinotVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Hayley PurcellNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, United States.
Wentao ZhuNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, United States.
Danijel DjukovicNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, United States.
Congzhou LiuVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Tina FiedlerVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Martha DeMeulesVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Marco MielcarekClinical Research Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Sujatha SrinivasanVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Daniel RafteryNorthwest Metabolomics Research Center, Department of Anesthesiology and Pain Medicine, University of Washington, Seattle, WA, United States.
Michael WuPublic Health Sciences Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
Steven A PergamVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.
David N FredricksVaccine and Infectious Disease Division, Fred Hutchinson Cancer Center, Seattle, WA, United States.

Funding

Novel Computational Tools for Studying the Human MicrobiomeR01HG005966 · NHGRI · FRED HUTCHINSON CANCER RESEARCH CENTER · PI FREDRICKS, DAVID NEAL, MATSEN, FREDERICK ALBERT · 2010 to 2012
$1.5M
NHGRI NIH HHS R01 HG005966
6 · The paper itself

Abstract

Introduction: Allogeneic hematopoietic cell transplantation (HCT) can cure hematologic malignancies, but 30-70% of recipients experience acute graft-versus-host disease (GvHD). GvHD is associated with perturbations in the gut microbiome. Bile acids are host derived compounds that are transformed by gut bacteria and bind to specific host cell receptors, informing our hypothesis that changes in bile acid-metabolizing gut bacteria alter bile acid levels to affect gut physiology and immunity during GvHD. Methods: In a longitudinal case-control study of patients with and without acute gut GvHD, we characterized bile acid concentrations and the gut microbiome in stool. Results: Primary and conjugated bile acid levels were similar regardless of gut GvHD status, but endogenous secondary bile acid concentrations were associated with gut GvHD ( Discussion: This provides evidence that acute gut GvHD patients are deficient in microbial

Indexed as

bai operonbile acid metabolismbile salt hydrolasegraft-versus-host diseasegut microbiomehematopoietic cell transplantmetabolomicsmetagenomics

Identifiers

PMID42495148
PMCPMC13391574

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.